Diabetes & Metabolism

Article	Citations
Contents - page 1	92
Diuretics and risk of major adverse limb events in patients with type-2 diabetes: An observational retrospective study	72
Analysis of glycemic control in diabetic patients by monitoring HbA1c levels before, during and after Covid-19 confinement in Auvergne, France	69
Editorial board	62
Cost analysis of continuous glucose monitoring in patients hospitalized in a diabetes department	49
Discontinuation of hemodialysis after correction of a major hypothyroidism episode, A case report	47
Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: An active-controlled randomised trial	39
Editorial board	37
Contents	37
Associations of young onset age and genetic risk of beta cell dysfunction with glycaemic progression in individuals with type 2 diabetes	35
Association between adipose deposition and mortality among adults without major cardiovascular risk factors	35
The significance of ophthalmological evaluation in the correct diagnosis of pediatric insulin-dependent diabetes mellitus: lessons from novel WFS1 variants	33
Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients	32
Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood	31
Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis	31
Obesity rather than diabetes impacted severe Covid-19 on reunion island: A retrospective cohort study from a frontline hospital, 2020–2021	30
Comment on “Elevated triglyceride–glucose index predicts risk of incident ischemic stroke: The Rural Chinese cohort study”	30
Cardiovascular protection significantly depends on HbA1c improvement with GLP-1RAs but not with SGLT2 is in type 2 diabetes: A narrative review	29
Eleven-year trends in socioeconomic inequalities in the prevalence and incidence of pharmacologically treated type 2 diabetes in France, 2010–2020	28
Efficacy / safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes	28
Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes	27
Concise review of lipidomics in nonalcoholic fatty liver disease	26
Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes	26
Mitochondrial heteroplasmy-phenotype correlation and response to glucose lowering therapy in subjects with m.3243A>G mutations	26
Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variability	25

Sommaire	25
Contents	25
1-h post-load plasma glucose for detecting early stages of prediabetes	25
Musculoskeletal disorders in type 1 diabetes: Clinical phenotyping and associations with quality of life and glucose control - The French SFDT1 cohort study	24
Objective and subjective sleep measures are associated with HbA1c and insulin sensitivity in the general population: Findings from the ORISCAV-LUX-2 study	23
Prevalence of NAFLD, MAFLD, and MASLD: NHANES 1999-2018	23
Type B insulin resistance syndrome: A case report	21
Correspondence for “Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring”	20
Comment on Gaudillère et al. Effects of remote care of patients with poorly controlled type 1 diabetes included in an experimental telemonitoring programme [Diabetes Metab 2021 Apr 13; 101251]	20
Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes	20
HbA1c at the time of testing for gestational diabetes identifies women at risk for pregnancy complications	20
Methylamine metabolites and progression to kidney failure in type 2 diabetes: An Asian and European prospective study	19
Averaged glycaemic variability or by average: More than a simple question of wording	19
Efficacy and safety of pharmacological treatments for gestational diabetes: a systematic review comparing metformin with glibenclamide and insulin	18
Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT	18
Euglycaemic diabetic ketosis decompensation under dapagliflozin in a patient with MODY3	18
Glucose management indicator: Do we need device-specific equations?	18
Monitoring gestational diabetes mellitus patients with myDiabby Healthcare® smartphone application vs classical diary. Results from the non-inferiority TELESUR-GDM study	17
Editorial board	16
Contents - Page 1	15
Diabetes prevalence, awareness, and control in the United States, 2017-2023	15
Editorial board	15
Age-related difference in the impact of diabetes mellitus on all-cause mortality after acute myocardial infarction	15
Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease	15
Effects of smoking behavior change on diabetes incidence after cancer development: A nationwide cohort study	15
Transitions in metabolic health status over time and risk of heart failure: A prospective study	14
Insulin pump initiation in outpatient settings: When technology facilitates new healthcare organizations	14
Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus	14
The association between metformin treatment and COVID-19 outcomes according to metformin continuation during hospitalisation	14
Residual risk associations between initial hyperglycemia and adverse pregnancy outcomes in a large cohort including 6709 women with gestational diabetes	14
Do diabetic complications influence cancer-related events in people with type 2 diabetes? A cohort approach	14
Contents - page 1	13
Glucagon like peptide-1 receptor agonists in type 1 diabetes	13
Glycemic Risk Index (GRI) variability in type 1 diabetes adults with HbA1c ≤ 7%: Insights for clinical evaluation and intervention	13
Contents	13
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies	13
Acute kidney injury is associated with liver-related events in patients with metabolic dysfunction-associated fatty liver disease	12
Editorial board	11
Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV rand	11
Association of podocyte ultrastructural changes with proteinuria and pathological classification in type 2 diabetic nephropathy	11
Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design	11
Contents	11
Fewer Type A personality traits in type 2 diabetes patients with diabetic foot ulcer	11
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus	11
Perirenal fat and chronic kidney disease in type 2 diabetes: The mediation role of afferent arteriolar resistance	11
Understanding the link between different types of maternal diabetes and the onset of autism spectrum disorders	10
Effect of SGLT2 inhibitors versus DPP4 inhibitors on major and non-major osteoporotic fracture risks among general and high-risk type 2 diabetes patients: A nationwide retrospective cohort study	10
Effect of glucagon-like peptide 1 receptor agonists on the renal protection in patients with type 2 diabetes: A systematic review and meta-analysis	10
Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,380 adults using serial echocardiography	10
Secukinumab (Anti-IL-17) induces clinical regression in early diagnosed type 1 diabetes: A case report	10

Trajectories of metabolic risk factors during the development of type 2 diabetes in Chinese adults	10
Diabetic ketoacidosis and mortality in COVID-19 infection	10
Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs	10
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus	10
Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan	9
Effects of remote care of patients with poorly controlled type 1 diabetes included in an experimental telemonitoring programme	9
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United States	9
Safety of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with diabetes mellitus	9
Impact of different types of hypertensive disorders of pregnancy and their duration on incident post-partum risk of diabetes mellitus: Results from the French nationwide study CONCEPTION	9
Editorial board	9
One-hour post-load glucose is associated with biopsy-proven metabolic dysfunction-associated steatotic liver disease in obese individuals	9
Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists	9
The impact of canagliflozin on the risk of neuropathy events: A post-hoc exploratory analysis of the CREDENCE trial	8
Effect of dietary reinforcement combined or not with GLP-1 receptor agonist therapy on histological outcomes in MASLD among patients with type 2 diabetes	8
Global Burden of type 2 diabetes in non-elderly individuals 1990 to 2021 and projections for 2050: a systematic analysis of the 2021 Global Burden of Disease	8
Editorial board	8
Comparisons of the risks of new-onset prostate cancer in type 2 diabetes mellitus between SGLT2I and DPP4I users: A population-based cohort study	8
Editorial board	8
Short course corticosteroid treatment and closed-loop insulin delivery system: The experience of the DBLG1 pre-launch	7
Automated insulin delivery for people living with Type 1 Diabetes in France: A long road ahead	7
Glycaemic variabilities: Key questions in pursuit of clarity	7
Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism?	7
The progressive uncoupling of maternal insulin clearance and insulin sensitivity across gestation	7
Association of daily sleep duration with risk of metabolic dysfunction-associated steatotic liver disease and adverse liver outcomes	7
Heart failure hospitalisation relative to major atherosclerotic events in type 2 diabetes with versus without chronic kidney disease: A meta-analysis of cardiovascular outcomes trials	7
Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19	7
Characteristics of newly diagnosed type 1 diabetes in paediatric and adult population from Reims University Hospital, France from 1997 to 2019	7
Contents	7
Impact of chronic emotions and psychosocial stress on glycemic control in patients with type 1 diabetes. Heterogeneity of glycemic responses, biological mechanisms, and personalized medical treatment	7
Risk of sepsis and pneumonia in patients initiated on SGLT2 inhibitors and DPP-4 inhibitors	7
Prevalence and risk of diabetic complications in young-onset versus late-onset type 2 diabetes mellitus	6
Leisure-time physical activity and mortality risk in type 2 diabetes: A nationwide cohort study	6
Trajectories of social isolation and loneliness and the risk of incident type 2 diabetes mellitus across genetic risk score	6
A high lean body mass is not protecting from type 2 diabetes in the presence of a high body fat mass	6
Exposure to persistent organic pollutants and the risk of type 2 diabetes: a case-cohort study	6
Increased risk of renal events in people with diabetic foot disease: A longitudinal observational study	6
Sommaire	6
Association between blood urea nitrogen-to-creatinine ratio and insulin sensitivity	6
Glucagon-like peptide 1 receptor agonists and renal outcomes in kidney transplant recipients with diabetes mellitus	6
Serum albumin and risk of incident diabetes and diabetic microvascular complications in the UK Biobank cohort	6
Association between diabetes and stress-induced hyperglycemia with skeletal muscle gene expression of INSR in critically ill patients: A prospective cohort study	6
Metabolic dysfunction-associated fatty liver disease and risk of incident chronic kidney disease: A nationwide cohort study	6
Exploring perceived barriers to physical activity among individuals with type 1 diabetes in the era of new technologies: An analysis from the BETTER registry	6
Risks of carpal tunnel syndrome and carpal tunnel release surgery in users of sodium-glucose cotransporter 2 inhibitors and glucagon-like peptide-1 receptor agonists: A target trial emulation study	6
Glucose-lowering agents and risk of ventricular arrhythmias and sudden cardiac death: A comprehensive review ranging from sulphonylureas to SGLT2 inhibitors	6
Reproductive factors, genetic susceptibility and risk of type 2 diabetes: A prospective cohort study	6
Treatment of women with mild gestational diabetes mellitus decreases the risk of adverse perinatal outcomes	6
Do SGLT2 inhibitors and GLP-1 receptor agonists modulate differently the risk of stroke ? Discordance between randomised controlled trials and observational studies	6
Incidence of new-onset type 1 diabetes during Covid-19 pandemic: A French nationwide population-based study	6
Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring	5
The switch from rapid-acting to concentrated regular insulin improves glucose control in type 2 diabetes patients on pump therapy: A cohort survey	5
Phthalates exposure, biological aging, and increased risks of insulin resistance, prediabetes, and diabetes in adults with metabolic dysfunction-associated steatotic liver disease	5
Lipoatrophic diabetes in familial partial lipodystrophy type 2: From insulin resistance to diabetes	5
Editorial board	5
Microalbuminuria screening in patients with ST-elevation myocardial infarction	5
Relationship of ultra-processed food consumption and new-onset chronic kidney diseases among participants with or without diabetes	5
Eye disorders other than diabetic retinopathy in patients with diabetes	5
Non-dioxin-like polychlorinated biphenyls (NDL-PCBs) dietary exposure is associated with an increased risk of type 2 diabetes in the European prospective investigation into cancer and nutrition (EPIC)	5
Impaired auditory neural performance, another dimension of hearing loss in type-2 diabetes mellitus	5
Low hemoglobin, even within the normal range, is associated with diabetic kidney disease	5
Addition of fenofibrate to statins is associated with risk reduction of diabetic retinopathy progression in patients with type 2 diabetes and metabolic syndrome: A propensity-matched cohort study	5
Cardiac arrhythmias and electrophysiologic responses during spontaneous hyperglycaemia in adults with type 1 diabetes mellitus	5
A very rare cause of markedly elevated CA 19–9: Glucagon-like peptide-1 receptor agonists	5
Impact of gender on relative rates of cardiovascular events in patients with diabetes	5
Post-translational modifications of apolipoproteins as promising biomarkers for diabetes-related cardiovascular diseases: A comprehensive review	5
Canagliflozin could improve the levels of renal oxygenation in newly diagnosed type 2 diabetes patients with normal renal function	5
Contents	5
Persistent gaps in the implementation of lipid-lowering therapy in patients with established atherosclerotic cardiovascular disease: A French nationwide study	5
Risk of rotator cuff tear and rotator cuff repair surgery comparison between sodium-glucose cotransporter 2 inhibitors and glucagon like peptide-1 receptor agonists: A real-world study	4
Glucagon-like peptide-1 receptor agonists and acute pancreatitis	4
Editorial board	4
Editorial board	4
Overweight and risk of type 2 diabetes: A prospective Chinese twin study	4
Early varicella infection is associated with a delayed onset of childhood type 1 diabetes	4
Key indices of glycaemic variability for application in diabetes clinical practice	4
Gut-muscle communication links FGF19 levels to the loss of lean muscle mass following rapid weight loss	4
Association between gastrectomy and the risk of type 2 diabetes in gastric cancer survivors: A nationwide cohort study	4
Editorial board	4
Editorial board	4
Comment on Orsi et al. Retinopathy as an independent predictor of all-cause mortality in individuals with type 2 diabetes [Diabetes Metab, 2023 Mar, 101413]	4

Closed-loop insulin delivery systems in patients with pancreatitis or pancreatectomy-induced diabetes: A case series	4
Self-reported haemoglobin A1c highly agrees with laboratory-measured haemoglobin A1c among adults living with type 1 diabetes: A BETTER registry study	4
Regular use of ibuprofen or paracetamol and incident type 2 diabetes: A prospective cohort study in the UK Biobank	4
Editorial board	4
β-hydroxybutyrate as a biomarker of β-cell function in new-onset type 2 diabetes and its association with treatment response at 6 months	4
Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: A longitudinal observational study	4
High Intensity Interval Training reduces hypoglycemic events compared with continuous aerobic training in individuals with type 1 diabetes	4
Circulating levels of GDF-15 for predicting cardiovascular and cancer morbidity and mortality in type 2 diabetes: Findings from Da Qing IGT and Diabetes Study	4
Cardiovascular and renal effects of the combination therapy of a GLP-1 receptor agonist and an SGLT2 inhibitor in observational real-life studies	4
Dose–response relationship between serum fibroblast growth factor 21 and liver fat content in non-alcoholic fatty liver disease	4
Improved dyspeptic symptoms of type 1 diabetes adults with gastroparesis on hybrid closed loop system: A case series	3
Continuous glucose monitoring‑derived time in range and CV are associated with elevated risk of adverse kidney outcomes for patients with type 2 diabetes	3
Cutaneous hypersensitivity reaction to dulaglutide: A case report of an allergic reaction	3
Contents	3
Hip fractures and type 2 diabetes in the elderly: Risk factors analysis of the Nedices cohort	3
Management of diabetes in patients hospitalized for acute cardiac events: Joint position paper from the French Society of Cardiology and the French-speaking Diabetes Society	3
The association of sweetened beverage intake with risk of type 2 diabetes in an Australian population: A longitudinal study	3
Dapagliflozin increases retinal thickness in type 2 diabetic patients as compared with glibenclamide: A randomized controlled trial	3
Contents	3
Cardiorenal outcomes and safety of SGLT2 inhibitors in patients with diabetes secondary to disorders of the exocrine pancreas: a nationwide population-based study	3
Association between sodium glucose co-transporter 2 inhibitors and incident glaucoma in patients with type 2 diabetes: A multi-institutional cohort study in Taiwan	3
Prevention of exercise-induced hypoglycemia in 12 patients with type 1 diabetes running the Paris Marathon using continuous glucose monitoring: A prospective, single-center observational study	3
Variable incidence of ketoacidosis in youth with type 1 diabetes onset during COVID-19 pandemic peaks in France	3
Elevation of hemoglobin A1c increases the risk of decline in left ventricular systolic function among patients with coronary artery disease	3
Comparative effectiveness of SGLT2 inhibitors and GLP-1 receptor agonists in preventing Alzheimer's disease, vascular dementia, and other dementia types among patients with type 2 diabetes	3
Prediction of cardiovascular events by skin auto-fluorescence: the DIABAGE follow-up study	3
French National Authority for Health assessment of metabolic surgery for type 2 diabetes remission—A meta-analysis in patients with class I to III obesity	3
Liraglutide reduces plasma PCSK9 in patients with type 2 diabetes not treated with statins	3
Gestational diabetes is associated with SARS-CoV-2 infection during pregnancy: A case-control study	3
Practical implementation of automated insulin delivery systems in 2025: A French position statement update	3
Plasma level of ATPase inhibitory factor 1 (IF1) is associated with type 2 diabetes risk in humans: A prospective cohort study	3
Smoking and diabetes interplay: A comprehensive review and joint statement	3